KPIs & Operating Metrics(New)
Growth Metrics

Johnson & Johnson (JNJ) FCF Payout Ratio Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Cover Growth (1y) (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn - -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn -94.03%
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn 141.61%
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn -58.56%
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn -58.88%
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn -29.55%
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn -29.45%
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn -18.46%
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn 128.23%
10 Gsk 88.34 Bn 83.66 Bn - -

Historic Data

Download Data 🔒
DateValue
Mar 29, 2026 141.61%
Dec 28, 2025 2.99%
Sep 28, 2025 -8.80%
Jun 29, 2025 72.19%
Mar 30, 2025 -12.13%
Dec 29, 2024 21.66%
Sep 29, 2024 -2.63%
Jun 30, 2024 -36.61%
Mar 31, 2024 -18.08%
Dec 31, 2023 -76.86%
Apr 2, 2023 48.69%
Apr 3, 2022 5.59%
Oct 3, 2021 6.40%
Jul 4, 2021 -34.94%
Apr 4, 2021 -14.60%
Jan 3, 2021 -22.18%
Sep 27, 2020 -5.62%
Jun 28, 2020 93.14%
Mar 29, 2020 10.44%
Dec 29, 2019 -0.59%
Sep 29, 2019 -16.80%
Jun 30, 2019 6.33%
Mar 31, 2019 8.59%
Dec 30, 2018 5.55%
Sep 30, 2018 7.59%
Jul 1, 2018 4.28%
Apr 1, 2018 -17.17%
Dec 31, 2017 -41.96%
Apr 2, 2017 -30.88%
Apr 3, 2016 59.76%
Sep 27, 2015 -23.02%
Jun 28, 2015 4.77%
Mar 29, 2015 47.37%
Dec 28, 2014 -8.40%
Sep 28, 2014 39.07%
Jun 29, 2014 -2.78%
Mar 30, 2014 -43.80%
Dec 29, 2013 -9.58%
Sep 29, 2013 -7.45%
Jun 30, 2013 -5.64%
Mar 31, 2013 47.82%
Dec 30, 2012 -88.85%
Apr 1, 2012 -13.30%
Apr 3, 2011 92.03%
Oct 3, 2010 11.53%
Jul 4, 2010 -7.59%
Apr 4, 2010 -22.97%